1. Home
  2. HTB vs VALN Comparison

HTB vs VALN Comparison

Compare HTB & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTB
  • VALN
  • Stock Information
  • Founded
  • HTB 1926
  • VALN 2012
  • Country
  • HTB United States
  • VALN France
  • Employees
  • HTB N/A
  • VALN 713
  • Industry
  • HTB
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HTB
  • VALN Health Care
  • Exchange
  • HTB NYSE
  • VALN Nasdaq
  • Market Cap
  • HTB 656.5M
  • VALN 645.1M
  • IPO Year
  • HTB N/A
  • VALN 2021
  • Fundamental
  • Price
  • HTB $40.63
  • VALN $7.68
  • Analyst Decision
  • HTB Buy
  • VALN Strong Buy
  • Analyst Count
  • HTB 2
  • VALN 3
  • Target Price
  • HTB $44.00
  • VALN $15.33
  • AVG Volume (30 Days)
  • HTB 58.0K
  • VALN 38.8K
  • Earning Date
  • HTB 07-22-2025
  • VALN 08-12-2025
  • Dividend Yield
  • HTB 1.16%
  • VALN N/A
  • EPS Growth
  • HTB N/A
  • VALN N/A
  • EPS
  • HTB 3.43
  • VALN N/A
  • Revenue
  • HTB $201,616,000.00
  • VALN $201,099,222.00
  • Revenue This Year
  • HTB $6.54
  • VALN $18.74
  • Revenue Next Year
  • HTB $1.75
  • VALN $29.26
  • P/E Ratio
  • HTB $12.02
  • VALN N/A
  • Revenue Growth
  • HTB 7.08
  • VALN 21.64
  • 52 Week Low
  • HTB $30.95
  • VALN $3.62
  • 52 Week High
  • HTB $41.78
  • VALN $8.66
  • Technical
  • Relative Strength Index (RSI)
  • HTB N/A
  • VALN 78.51
  • Support Level
  • HTB N/A
  • VALN $5.95
  • Resistance Level
  • HTB N/A
  • VALN $8.50
  • Average True Range (ATR)
  • HTB 0.00
  • VALN 0.37
  • MACD
  • HTB 0.00
  • VALN 0.18
  • Stochastic Oscillator
  • HTB 0.00
  • VALN 70.82

About HTB HOMETRUST BANCSHARES INC

HomeTrust Bancshares Inc operates as a bank holding company. It engaged in the business of planning, directing and coordinating the business activities of the Bank. The Bank is a North Carolina state chartered bank and provides a range of retail and commercial banking products. Company's principal business consists of attracting deposits from the general public and investing those funds, along with borrowed funds, in commercial real estate loans, construction and development loans, commercial and industrial loans, equipment finance leases, municipal leases, loans secured by first and second mortgages on one-to-four family residences including home equity loans and other consumer loans.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: